Comparative effectiveness of chimeric antigen receptor (CAR) T‐cell therapy versus historical controls in patients with relapse/refractory aggressive B‐cell lymphoma: An indirect treatment comparison in the real‐world setting

Pierre J. A. Villeneuve, Lee Mozessohn, Nibene H. Somé, Rebecca E. Mercer, Lisa Masucci, Tom Kouroukis, Chris Bredeson, Suriya Aktar, Qi Guan, Anca Prica, Christine I. Chen, Danielle Rodin, Matthew Cheung, Munaza Chaudhry, Scott Gavura, Cassandra McKay, William W. L. Wong, Kelvin K. W. Chan

Open source

DOI: 10.1111/bjh.70632
Published: 2026-07-06
Container: British Journal of Haematology
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/bjh.70632,
  title = {Comparative effectiveness of chimeric antigen receptor (CAR) T‐cell therapy versus historical controls in patients with relapse/refractory aggressive B‐cell lymphoma: An indirect treatment comparison in the real‐world setting},
  author = {Pierre J. A. Villeneuve and Lee Mozessohn and Nibene H. Somé and Rebecca E. Mercer and Lisa Masucci and Tom Kouroukis and Chris Bredeson and Suriya Aktar and Qi Guan and Anca Prica and Christine I. Chen and Danielle Rodin and Matthew Cheung and Munaza Chaudhry and Scott Gavura and Cassandra McKay and William W. L. Wong and Kelvin K. W. Chan},
  year = {2026},
  journal = {British Journal of Haematology},
  doi = {10.1111/bjh.70632},
  url = {https://doi.org/10.1111/bjh.70632}
}

RIS

TY  - JOUR
TI  - Comparative effectiveness of chimeric antigen receptor (CAR) T‐cell therapy versus historical controls in patients with relapse/refractory aggressive B‐cell lymphoma: An indirect treatment comparison in the real‐world setting
AU  - Pierre J. A. Villeneuve
AU  - Lee Mozessohn
AU  - Nibene H. Somé
AU  - Rebecca E. Mercer
AU  - Lisa Masucci
AU  - Tom Kouroukis
AU  - Chris Bredeson
AU  - Suriya Aktar
AU  - Qi Guan
AU  - Anca Prica
AU  - Christine I. Chen
AU  - Danielle Rodin
AU  - Matthew Cheung
AU  - Munaza Chaudhry
AU  - Scott Gavura
AU  - Cassandra McKay
AU  - William W. L. Wong
AU  - Kelvin K. W. Chan
PY  - 2026
JO  - British Journal of Haematology
DO  - 10.1111/bjh.70632
UR  - https://doi.org/10.1111/bjh.70632
ER  -

APA

Villeneuve, P. J. A., Mozessohn, L., Somé, N. H., Mercer, R. E., Masucci, L., Kouroukis, T., Bredeson, C., Aktar, S., Guan, Q., Prica, A., Chen, C. I., Rodin, D., Cheung, M., Chaudhry, M., Gavura, S., McKay, C., Wong, W. W. L., & Chan, K. K. W. (2026). Comparative effectiveness of chimeric antigen receptor (CAR) T‐cell therapy versus historical controls in patients with relapse/refractory aggressive B‐cell lymphoma: An indirect treatment comparison in the real‐world setting. British Journal of Haematology. https://doi.org/10.1111/bjh.70632

Source records

crossref · retrieved 2026-09-25T03:18:26.226Z